瘧疾治療市場規模和預測、全球和區域佔有率、趨勢和成長機會分析報告範圍:按治療、給藥途徑和配銷通路
市場調查報告書
商品編碼
1389643

瘧疾治療市場規模和預測、全球和區域佔有率、趨勢和成長機會分析報告範圍:按治療、給藥途徑和配銷通路

Malaria Treatment Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment, Route of Administration, and Distribution Channel

出版日期: | 出版商: The Insight Partners | 英文 320 Pages | 訂單完成後即時交付

價格

瘧疾治療市場預計將從2022年的32.96億美元成長到2030年的244.87億美元;預計2022年至2030年複合CAGR為28.5%。由於低收入國家瘧疾流行率高以及國際和國家組織發起的全球瘧疾消除計劃,瘧疾治療市場正在不斷成長。此外,先進診斷工具的推出數量不斷增加,以及提供有效治療方法的研究活動不斷增加,也進一步推動了市場的成長。然而,假冒抗瘧藥和隨後的抗藥性等因素限制了市場的成長。

根據世界衛生組織 (WHO) 最新發布的《2020 年世界瘧疾報告》(WMR),全球報告了 2.41 億例瘧疾病例,而 2019 年記錄的病例數為 2.27 億例。瘧疾造成的死亡人數每年增加69,000人。其中約三分之二(即 47,000 人)是由於 COVID-19 爆發期間醫療服務中斷造成的;其餘三分之一的死亡人數,即 22,000 人,反映了世界衛生組織計算瘧疾死亡率的方法最近發生的變化(不考慮 COVID-19 的干擾)。

世衛組織非洲區域在全球瘧疾負擔中所佔比例高。 2020 年,全球約 95% 的瘧疾病例和約 96% 的死亡發生在非洲,約 80% 的死亡病例為 5 歲及以下兒童。據世界衛生組織稱,奈及利亞、坦尚尼亞、剛果民主共和國和莫三比克這四個非洲國家的瘧疾相關死亡人數約佔全球報告的一半。根據《2020 年柳葉刀區域衛生》報告,非洲國家的瘧疾負擔最高;惡性瘧原蟲是導致 5 歲以下兒童死亡率最高的重要原因,佔全球約 77%;在非洲國家,惡性瘧原蟲約佔兒童瘧疾死亡率的 96%。間日瘧原蟲佔瘧疾病例總數的 2%(450 萬),主要來自亞洲。根據《WMR 2021》,東南亞國家記錄了約 2% 的全球瘧疾負擔,其中印度佔 2020 年估計瘧疾病例的 83%,以及 82% 的死亡與瘧疾相關。因此,東南亞國家的瘧疾盛行率不斷上升全球不同地區推動了瘧疾治療市場的成長。

全球瘧疾高發國家的政府正在採取各種策略,透過改善人民獲得醫療保健服務(包括治療選擇)的機會來根除這種疾病。採取的一些措施如下:

緬甸制定了全球基金批准的國家瘧疾控制計劃,預計2030年將消除惡性瘧原蟲引起的疾病。該國的全民健保覆蓋還包括透過顯微鏡或快速診斷測試(RDT)和基於青蒿素的聯合療法(ACT)進行瘧疾診斷。

泰國政府實施了2017-2026年國家瘧疾消除策略(NMES),進一步實施綜合消除策略,旨在在2024年根除這種疾病。

2020年1月,非洲瘧疾企業聯盟(CAMA)啟動了2021-2023年策略計劃,旨在透過瘧疾控制干涉措施惠及數百萬人,從而擴大非洲的預防活動。

因此,上述旨在傳播瘧疾疾病意識的措施加強了根除瘧疾的努力,從而促進了瘧疾治療市場的成長。

該報告將瘧疾治療市場細分如下:

根據治療方法,瘧疾治療市場分為學名藥、原廠藥、疫苗等。根據給藥途徑,瘧疾治療市場分為口服和腸胃外。根據配銷通路,瘧疾治療市場分為直接招標、醫院藥房、零售藥房、網路藥房等。依地理位置分類,瘧疾治療市場分為北美(美國、加拿大和墨西哥)、歐洲(英國、德國、法國、義大利、西班牙和歐洲其他地區)、亞太地區(中國、日本、印度、澳洲、韓國和亞太地區其他地區)、中東和非洲(沙烏地阿拉伯、阿拉伯聯合大公國、南非、肯亞、坦尚尼亞、盧安達、奈及利亞、加納、烏幹達、安哥拉、喀麥隆、塞內加爾、尚比亞和其他地區)中東和非洲)以及南美洲和中美洲(巴西、阿根廷以及南美洲和中美洲其他地區)。

基於治療的見解

瘧疾治療市場依治療分為學名藥、原廠藥、疫苗等。疫苗細分市場在 2022 年佔據最大的市場佔有率。疫苗提供針對特定傳染病的主動獲得性免疫力。由於研發活動的增加和候選疫苗管道的增加,瘧疾疫苗市場正在以顯著的速度成長。

基於管理的洞察之路

根據給藥途徑,瘧疾治療市場分為口服、腸胃外和靜脈注射。 2022年,口服細分市場佔最大市場佔有率;然而,預計注射劑領域在預測期內的CAGR最高。口服給藥是最優選和最合適的給藥途徑,因為它提供了高患者依從性、非侵入性、最少的無菌限制、成本效益、劑型設計的靈活性以及製造過程的簡便性。易於給藥和長期成本效益等優點是推動口服藥物採用的主要因素。

基於配銷通路的見解

根據分銷管道,瘧疾治療市場分為直接招標、醫院藥房、零售藥房、網路藥房等。 2022年直接招標部分佔據最大市場佔有率;然而,線上藥局領域預計在預測期內CAGR最高。口服給藥是最優選和最合適的給藥途徑,因為它提供了高患者依從性、非侵入性、最少的無菌限制、成本效益、劑型設計的靈活性以及製造過程的簡便性。易於給藥和長期成本效益等優點是推動口服藥物採用的主要因素。

在準備瘧疾治療市場報告時提到的一些主要一手和二手來源包括世界衛生組織 (WHO)、美國人口普查局和疾病預防控制中心等。

目錄

第 1 章:簡介

  • Insight Partners 研究報告指南
  • 市場區隔

第 2 章:執行摘要

  • 主要見解 - 瘧疾

第 3 章:研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章:瘧疾治療市場格局

  • 概述
  • PEST 分析 - 瘧疾治療

第 5 章:瘧疾治療市場 - 主要產業動態

  • 主要市場促進因素:
    • 瘧疾盛行率增加
    • 提高人們對瘧疾認知的措施不斷增多
  • 市場限制
    • 假冒抗瘧藥物的出現導致抗藥性的出現
  • 市場機會
    • 市場參與者不斷增加的策略性舉措
  • 未來的趨勢
    • 擴大新藥和疫苗的研發線
  • 影響分析

第 6 章:瘧疾治療市場 - 全球市場分析

  • 瘧疾治療市場收入,2022 - 2030
  • 地理分析市場收入,2022 - 2030

第 7 章:瘧疾治療市場 - 收入和 2030 年預測 - 按治療分類

  • 概述
  • 2022 年和 2030 年按治療分類的瘧疾治療市場收入佔有率 (%)
  • 疫苗
  • 學名藥
  • 發起人
  • 其他

第 8 章:瘧疾治療市場 - 2030 年收入和預測 - 按給藥途徑

  • 概述
  • 2022 年和 2030 年按給藥途徑分類的瘧疾治療市場收入佔有率 (%)
  • 口服
  • 注射用

第 9 章:瘧疾治療市場 - 2030 年收入和預測 - 按配銷通路

  • 概述
  • 2022 年和 2030 年按配銷通路分類的瘧疾治療市場收入佔有率 (%)
  • 直接招標
  • 醫院藥房
  • 零售藥局
  • 網路藥局
  • 其他

第 10 章:瘧疾治療市場 - 地理分析

  • 北美洲
      • 美國
      • 加拿大
      • 墨西哥
  • 歐洲
    • 法國
    • 英國
    • 義大利
    • 德國
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 亞太地區其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 肯亞
    • 坦尚尼亞
    • 盧安達
    • 奈及利亞
    • 迦納
    • 烏幹達
    • 安哥拉
    • 喀麥隆
    • 塞內加爾
    • 尚比亞
    • 中東和非洲其他地區
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地區

第 11 章:瘧疾治療市場產業格局

  • 概述
  • 瘧疾治療市場的成長策略
  • 無機成長策略
    • 概述
  • 有機成長策略
    • 概述

第 12 章:公司簡介

  • Cipla Ltd
  • Sun Pharmaceutical Industries Ltd
  • Sanofi SA
  • GSK Plc
  • Novartis AG
  • Pfizer Inc
  • AdvaCare Pharma USA LLC
  • VLP Therapeutics LLC
  • Lupin Ltd

第 13 章:附錄

  • 關於我們
  • 專業術語

第 14 章:附錄

Product Code: TIPRE00018229

The malaria treatment market is expected to grow from US$ 3.296 billion in 2022 to US$ 24.487 billion by 2030; it is estimated to grow at a CAGR of 28.5% from 2022 to 2030. The market for malaria treatment is growing due to the high prevalence of malaria in low-income countries and global malaria elimination programs initiated by international and national organizations. Also, the increasing number of launches of advanced diagnostic tools and rising research activities to provide effective therapeutics are further driving the growth of the market. However, factors such as a counterfeit antimalarial drug and subsequent drug resistance are restraining the market growth.

According to the latest World Malaria Report (WMR) 2020 from the World Health Organization (WHO), 241 million cases of malaria were reported in the world, in comparison to 227 million cases that were logged in 2019. According to the same source, the number of deaths caused due to malaria has an annual rise of 69,000 deaths. Approximately two-thirds of these deaths, i.e., 47,000, were caused by disruptions in healthcare services during the COVID-19 outbreak; the remaining one-third of deaths, i.e., 22,000 reflected a recent change in the WHO's methodology for calculating malaria mortality (irrespective of COVID-19 disruptions).

The WHO African region accounted for a high share of the global burden of malaria. In 2020, ~95% of global cases and ~96% of deaths were reported in Africa due to malaria, and ~80% of the total deaths that were reported were in children aged 5 and below. According to the WHO, four African countries, Nigeria, Tanzania, the Democratic Republic of the Congo, and Mozambique, recorded approximately half of all malaria-related deaths that were reported globally. According to the LANCET Regional Health 2020, African countries had the highest burden of malaria; P. falciparum is a notable cause of the highest mortality rates in children younger than 5, which accounts for ~77% across the world; in African countries, P. falciparum accounts for ~96% of total mortalities caused among children by malaria. P. vivax has been a causal agent of 2% (4.5 million) of the total cases of malaria, mainly from Asia. According to WMR 2021, ~2% of the global burden of malaria was recorded by Southeast Asian countries, where India accounted for 83% of estimated malaria cases and 82% of deaths associate with malaria in 2020. Thus, the rising prevalence of malaria in different regions across the globe boosts the malaria treatment market growth.

Governments of various countries across the globe with a high prevalence of malaria are deploying various strategies to eradicate the disease by improving access to healthcare services, including treatment options, to the people. A few of the initiatives undertaken are as follows:

Myanmar has a national malaria control plan that the Global Fund has approved, and by 2030, it is expected to eliminate the disease caused by P. falciparum. The universal healthcare coverage in the country also includes access to malaria diagnosis by means of microscopy or rapid diagnostic tests (RDTs) and artemisinin-based combination therapies (ACTs).

The government of Thailand has implemented a National Malaria Elimination Strategy (NMES) 2017-2026 that further applies an integrated elimination strategy that aims to eradicate the disease by 2024.

In January 2020, the Corporate Alliance on Malaria in Africa (CAMA) launched a strategic plan for 2021-2023 with an aim to reach millions of people through malaria control interventions and thereby scale up prevention activities in Africa.

Thus, the abovementioned initiatives to spread awareness about malaria disease reinforce the eradication efforts to bolster the malaria treatment market growth.

The report segments the malaria treatment market as follows:

Based on treatment, the malaria treatment market is segmented into generic drugs, originators, vaccines, and others. Based on route of administration, the malaria treatment market is divided into oral and parenteral. Based on distribution channel, the malaria treatment market is segmented into direct tender, hospital pharmacies, retail pharmacies, online pharmacies, and others. By geography, the malaria treatment market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia Pacific), the Middle East & Africa (Saudi Arabia, the UAE, South Africa, Kenya, Tanzania, Rwanda, Nigeria, Ghana, Uganda, Angola, Cameroon, Senegal, Zambia, and Rest of the Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America).

Treatment-Based Insights

The malaria treatment market is segmented based on treatment into generic drugs, originators, vaccines, and others. vaccines segment held the largest market share in 2022. Vaccines provide active acquired immunity against particular infectious disease. The market for malaria vaccines is growing at a significant growth rate owing to increasing research and development activities and increasing pipeline of vaccine candidates.

Route of Administration-Based Insights

Based on route of administration, the malaria treatment market is bifurcated into oral and parenteral & intravenous. The oral segment accounted for the largest share of the market in 2022; however, the parenteral segment is expected to register the highest CAGR during the forecast period. Oral drug delivery is the most preferred and suitable route of drug administration as it offers high patient compliance, non-invasiveness, least sterility constraints, cost-effectiveness, flexibility in the design of dosage form and ease in the manufacturing process. Benefits such as ease of administration and long-term cost efficiency are major factors fueling the adoption of oral drugs.

Distribution Channel-Based Insights

Based on distribution channels, the malaria treatment market is segmented into direct tender, hospital pharmacies, retail pharmacies, online pharmacies, and others. The direct tender segment accounted for the largest share of the market in 2022; however, the online pharmacies segment is expected to register the highest CAGR during the forecast period. Oral drug delivery is the most preferred and suitable route of drug administration as it offers high patient compliance, non-invasiveness, least sterility constraints, cost-effectiveness, flexibility in the design of dosage form and ease in the manufacturing process. Benefits such as ease of administration and long-term cost efficiency are major factors fueling the adoption of oral drugs.

A few of the major primary and secondary sources referred to while preparing the report on the malaria treatment market are the World Health Organization (WHO), the US Census Bureau, and CDC, among others.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the malaria treatment market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global malaria treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights - Malaria

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Malaria Treatment Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis - Malaria Treatment

5. Malaria Treatment Market - Key Industry Dynamics

  • 5.1 Key Market Drivers:
    • 5.1.1 Increasing Prevalence of Malaria
    • 5.1.2 Rising Initiatives to Raise Awareness about Malaria
  • 5.2 Market Restraints
    • 5.2.1 Availability of Counterfeit Antimalarial Drugs Followed by Subsequent Drug Resistance
  • 5.3 Market Opportunities
    • 5.3.1 Growing Strategic Initiatives by Market Players
  • 5.4 Future Trends
    • 5.4.1 Extending Pipeline of New Drugs and Vaccines
  • 5.5 Impact Analysis

6. Malaria Treatment Market - Global Market Analysis

  • 6.1 Malaria Treatment Market Revenue (US$ million), 2022 - 2030
  • 6.2 Geography Analysis Market Revenue (US$ million), 2022 - 2030

7. Malaria Treatment Market - Revenue and Forecast to 2030 - by Treatment

  • 7.1 Overview
  • 7.2 Malaria Treatment Market Revenue Share, by Treatment 2022 & 2030 (%)
  • 7.3 Vaccines
    • 7.3.1 Overview
    • 7.3.2 Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
  • 7.4 Generic Drugs
    • 7.4.1 Overview
    • 7.4.2 Generic Drugs Market Revenue and Forecast to 2028 (US$ Mn)
  • 7.5 Originators
    • 7.5.1 Overview
    • 7.5.2 Originators Market Revenue and Forecast to 2028 (US$ Mn)
  • 7.6 Others
    • 7.6.1 Overview
    • 7.6.2 Others Market Revenue and Forecast to 2028 (US$ Mn)

8. Malaria Treatment Market - Revenue and Forecast to 2030 - by Route of Administration

  • 8.1 Overview
  • 8.2 Malaria Treatment Market Revenue Share, by Route of Administration 2022 & 2030 (%)
  • 8.3 Oral
    • 8.3.1 Overview
    • 8.3.2 Oral: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Parenteral
    • 8.4.1 Overview
    • 8.4.2 Parenteral: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)

9. Malaria Treatment Market - Revenue and Forecast to 2030 - by Distribution Channel

  • 9.1 Overview
  • 9.2 Malaria Treatment Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
  • 9.3 Direct Tender
    • 9.3.1 Overview
    • 9.3.2 Direct Tender: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Hospital Pharmacies
    • 9.4.1 Overview
    • 9.4.2 Hospital Pharmacies: Malaria Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.4.2.1.1 Malaria Treatment Market, by Hospital Pharmacies
  • 9.5 Retail Pharmacies
    • 9.5.1 Overview
    • 9.5.2 Retail Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.5.2.1.1 Malaria Treatment Market, by Retail Pharmacies
  • 9.6 Online Pharmacies
    • 9.6.1 Overview
    • 9.6.2 Online Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.7 Others
    • 9.7.1 Overview
    • 9.7.2 Others : Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)

10. Malaria Treatment Market - Geographical Analysis

  • 10.1 North America Malaria Treatment Market, Revenue and Forecast To 2030
    • 10.1.1 Overview
    • 10.1.2 Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
      • 10.1.2.1 North America: Malaria Treatment Market, by Treatment
      • 10.1.2.2 North America: Malaria Treatment Market, by Route of Administration
      • 10.1.2.3 North America: Malaria Treatment Market, by Distribution Channel
        • 10.1.2.3.1 North America: Malaria Treatment Market, by Hospital Pharmacies
        • 10.1.2.3.2 North America: Malaria Treatment Market, by Retail Pharmacies
      • 10.1.2.4 North America: Malaria Treatment Market, by Country
      • 10.1.2.5 US
      • 10.1.2.6 Overview
        • 10.1.2.6.1 US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.6.2 US: Malaria Treatment Market, by Treatment
        • 10.1.2.6.3 US: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.1.2.6.4 US: Malaria Treatment Market, by Distribution Channel
        • 10.1.2.6.4.1 US: Malaria Treatment Market, by Hospital Pharmacies
        • 10.1.2.6.4.2 US: Malaria Treatment Market, by Retail Pharmacies
      • 10.1.2.7 Canada
      • 10.1.2.8 Overview
        • 10.1.2.8.1 Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.8.2 Canada: Malaria Treatment Market, by Treatment
        • 10.1.2.8.3 Canada: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.1.2.8.4 Canada: Malaria Treatment Market, by Distribution Channel
        • 10.1.2.8.4.1 Canada: Malaria Treatment Market, by Hospital Pharmacies
        • 10.1.2.8.4.2 Canada: Malaria Treatment Market, by Retail Pharmacies
      • 10.1.2.9 Mexico
      • 10.1.2.10 Overview
        • 10.1.2.10.1 Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.10.2 Mexico: Malaria Treatment Market, by Treatment
        • 10.1.2.10.3 Mexico: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.1.2.10.4 Mexico: Malaria Treatment Market, by Distribution Channel
        • 10.1.2.10.4.1 Mexico: Malaria Treatment Market, by Hospital Pharmacies
        • 10.1.2.10.4.2 Mexico: Malaria Treatment Market, by Retail Pharmacies
  • 10.2 Europe Malaria Treatment Market, Revenue and Forecast To 2030
    • 10.2.1 Overview
    • 10.2.2 Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
      • 10.2.2.1 Europe: Malaria Treatment Market, by Treatment
      • 10.2.2.2 Europe: Malaria Treatment Market, by Route of Administration
      • 10.2.2.3 Europe: Malaria Treatment Market, by Distribution Channel
        • 10.2.2.3.1 Europe: Malaria Treatment Market, by Hospital Pharmacies
        • 10.2.2.3.2 Europe: Malaria Treatment Market, by Retail Pharmacies
      • 10.2.2.4 Europe: Malaria Treatment Market, by Countries
      • 10.2.2.5 France
      • 10.2.2.6 Overview
        • 10.2.2.6.1 France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.2.6.2 France: Malaria Treatment Market, by Treatment
        • 10.2.2.6.3 France: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.2.2.6.4 France: Malaria Treatment Market, by Distribution Channel
        • 10.2.2.6.4.1 France: Malaria Treatment Market, by Hospital Pharmacies
        • 10.2.2.6.4.2 France: Malaria Treatment Market, by Retail Pharmacies
      • 10.2.2.7 UK
      • 10.2.2.8 Overview
        • 10.2.2.8.1 UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.2.8.2 UK: Malaria Treatment Market, by Treatment
        • 10.2.2.8.3 UK: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.2.2.8.4 UK: Malaria Treatment Market, by Distribution Channel
        • 10.2.2.8.4.1 UK: Malaria Treatment Market, by Hospital Pharmacies
        • 10.2.2.8.4.2 UK: Malaria Treatment Market, by Retail Pharmacies
      • 10.2.2.9 Italy
      • 10.2.2.10 Overview
        • 10.2.2.10.1 Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.2.10.2 Italy: Malaria Treatment Market, by Treatment
        • 10.2.2.10.3 Italy: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.2.2.10.4 Italy: Malaria Treatment Market, by Distribution Channel
        • 10.2.2.10.4.1 Italy: Malaria Treatment Market, by Hospital Pharmacies
        • 10.2.2.10.4.2 Italy: Malaria Treatment Market, by Retail Pharmacies
      • 10.2.2.11 Germany
      • 10.2.2.12 Overview
        • 10.2.2.12.1 Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.2.12.2 Germany: Malaria Treatment Market, by Treatment
        • 10.2.2.12.3 Germany: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.2.2.12.4 Germany: Malaria Treatment Market, by Distribution Channel
        • 10.2.2.12.4.1 Germany: Malaria Treatment Market, by Hospital Pharmacies
        • 10.2.2.12.4.2 Germany: Malaria Treatment Market, by Retail Pharmacies
      • 10.2.2.13 Spain
      • 10.2.2.14 Overview
        • 10.2.2.14.1 Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.2.14.2 Spain: Malaria Treatment Market, by Treatment
        • 10.2.2.14.3 Spain: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.2.2.14.4 Spain: Malaria Treatment Market, by Distribution Channel
        • 10.2.2.14.4.1 Spain: Malaria Treatment Market, by Hospital Pharmacies
        • 10.2.2.14.4.2 Spain: Malaria Treatment Market, by Retail Pharmacies
      • 10.2.2.15 Rest of Europe
      • 10.2.2.16 Overview
        • 10.2.2.16.1 Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.2.16.2 Rest of Europe: Malaria Treatment Market, by Treatment
        • 10.2.2.16.3 Rest of Europe: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.2.2.16.4 Rest of Europe: Malaria Treatment Market, by Distribution Channel
        • 10.2.2.16.4.1 Rest of Europe: Malaria Treatment Market, by Hospital Pharmacies
        • 10.2.2.16.4.2 Rest of Europe: Malaria Treatment Market, by Retail Pharmacies
  • 10.3 Asia Pacific Malaria Treatment Market, Revenue and Forecast To 2030
    • 10.3.1 Overview
    • 10.3.2 Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
      • 10.3.2.1 Asia Pacific: Malaria Treatment Market, by Treatment
      • 10.3.2.2 Asia Pacific: Malaria Treatment Market, by Route of Administration
      • 10.3.2.3 Asia Pacific: Malaria Treatment Market, by Distribution Channel
        • 10.3.2.3.1 Asia Pacific: Malaria Treatment Market, by Hospital Pharmacies
        • 10.3.2.3.2 Asia Pacific: Malaria Treatment Market, by Retail Pharmacies
      • 10.3.2.4 Asia Pacific: Malaria Treatment Market, by Countries
      • 10.3.2.5 Japan
      • 10.3.2.6 Overview
        • 10.3.2.6.1 Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.2.6.2 Japan: Malaria Treatment Market, by Treatment
        • 10.3.2.6.3 Japan: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.3.2.6.4 Japan: Malaria Treatment Market, by Distribution Channel
        • 10.3.2.6.4.1 Japan: Malaria Treatment Market, by Hospital Pharmacies
        • 10.3.2.6.4.2 Japan: Malaria Treatment Market, by Retail Pharmacies
      • 10.3.2.7 India
      • 10.3.2.8 Overview
        • 10.3.2.8.1 India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.2.8.2 India: Malaria Treatment Market, by Treatment
        • 10.3.2.8.3 India: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.3.2.8.4 India: Malaria Treatment Market, by Distribution Channel
        • 10.3.2.8.4.1 India: Malaria Treatment Market, by Hospital Pharmacies
        • 10.3.2.8.4.2 India: Malaria Treatment Market, by Retail Pharmacies
      • 10.3.2.9 South Korea
      • 10.3.2.10 Overview
        • 10.3.2.10.1 South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.2.10.2 South Korea: Malaria Treatment Market, by Treatment
        • 10.3.2.10.3 South Korea: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.3.2.10.4 South Korea: Malaria Treatment Market, by Distribution Channel
        • 10.3.2.10.4.1 South Korea: Malaria Treatment Market, by Hospital Pharmacies
        • 10.3.2.10.4.2 South Korea: Malaria Treatment Market, by Retail Pharmacies
      • 10.3.2.11 Australia
      • 10.3.2.12 Overview
        • 10.3.2.12.1 Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.2.12.2 Australia: Malaria Treatment Market, by Treatment
        • 10.3.2.12.3 Australia: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.3.2.12.4 Australia: Malaria Treatment Market, by Distribution Channel
        • 10.3.2.12.4.1 Australia: Malaria Treatment Market, by Hospital Pharmacies
        • 10.3.2.12.4.2 Australia: Malaria Treatment Market, by Retail Pharmacies
      • 10.3.2.13 Rest of Asia Pacific
      • 10.3.2.14 Overview
        • 10.3.2.14.1 Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.2.14.2 Rest of Asia Pacific: Malaria Treatment Market, by Treatment
        • 10.3.2.14.3 Rest of Asia Pacific: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.3.2.14.4 Rest of Asia Pacific: Malaria Treatment Market, by Distribution Channel
        • 10.3.2.14.4.1 Rest of Asia Pacific: Malaria Treatment Market, by Hospital Pharmacies
        • 10.3.2.14.4.2 Rest of Asia Pacific: Malaria Treatment Market, by Retail Pharmacies
  • 10.4 Middle East & Africa Malaria Treatment Market, Revenue and Forecast To 2030
    • 10.4.1 Overview
    • 10.4.2 Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
      • 10.4.2.1 Middle East & Africa: Malaria Treatment Market, by Treatment
      • 10.4.2.2 Middle East & Africa: Malaria Treatment Market, by Route of Administration
      • 10.4.2.3 Middle East & Africa: Malaria Treatment Market, by Distribution Channel
        • 10.4.2.3.1 Middle East & Africa: Malaria Treatment Market, by Hospital Pharmacies
        • 10.4.2.3.2 Middle East & Africa: Malaria Treatment Market, by Retail Pharmacies
      • 10.4.2.4 Middle East & Africa: Malaria Treatment Market, by Country
      • 10.4.2.5 Saudi Arabia
      • 10.4.2.6 Overview
        • 10.4.2.6.1 Saudi Arabia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.2.6.2 Saudi Arabia: Malaria Treatment Market, by Treatment
        • 10.4.2.6.3 Saudi Arabia: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.4.2.6.4 Saudi Arabia: Malaria Treatment Market, by Distribution Channel
        • 10.4.2.6.4.1 Saudi Arabia: Malaria Treatment Market, by Hospital Pharmacies
        • 10.4.2.6.4.2 Saudi Arabia: Malaria Treatment Market, by Retail Pharmacies
      • 10.4.2.7 UAE
      • 10.4.2.8 Overview
        • 10.4.2.8.1 UAE: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.2.8.2 UAE: Malaria Treatment Market, by Treatment
        • 10.4.2.8.3 UAE: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.4.2.8.4 UAE: Malaria Treatment Market, by Distribution Channel
        • 10.4.2.8.4.1 UAE: Malaria Treatment Market, by Hospital Pharmacies
        • 10.4.2.8.4.2 UAE: Malaria Treatment Market, by Retail Pharmacies
      • 10.4.2.9 South Africa
      • 10.4.2.10 Overview
        • 10.4.2.10.1 South Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.2.10.2 South Africa: Malaria Treatment Market, by Treatment
        • 10.4.2.10.3 South Africa: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.4.2.10.4 South Africa: Malaria Treatment Market, by Distribution Channel
        • 10.4.2.10.4.1 South Africa: Malaria Treatment Market, by Hospital Pharmacies
        • 10.4.2.10.4.2 South Africa: Malaria Treatment Market, by Retail Pharmacies
      • 10.4.2.11 Kenya
      • 10.4.2.12 Overview
        • 10.4.2.12.1 Kenya: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.2.12.2 Kenya: Malaria Treatment Market, by Treatment
        • 10.4.2.12.3 Kenya: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.4.2.12.4 Kenya: Malaria Treatment Market, by Distribution Channel
        • 10.4.2.12.4.1 Kenya: Malaria Treatment Market, by Hospital Pharmacies
        • 10.4.2.12.4.2 Kenya: Malaria Treatment Market, by Retail Pharmacies
      • 10.4.2.13 Tanzania
      • 10.4.2.14 Overview
        • 10.4.2.14.1 Tanzania: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.2.14.2 Tanzania: Malaria Treatment Market, by Treatment
        • 10.4.2.14.3 Tanzania: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.4.2.14.4 Tanzania: Malaria Treatment Market, by Distribution Channel
        • 10.4.2.14.4.1 Tanzania: Malaria Treatment Market, by Hospital Pharmacies
        • 10.4.2.14.4.2 Tanzania: Malaria Treatment Market, by Retail Pharmacies
      • 10.4.2.15 Rwanda
      • 10.4.2.16 Overview
        • 10.4.2.16.1 Rwanda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.2.16.2 Rwanda: Malaria Treatment Market, by Treatment
        • 10.4.2.16.3 Rwanda: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.4.2.16.4 Rwanda: Malaria Treatment Market, by Distribution Channel
        • 10.4.2.16.4.1 Rwanda: Malaria Treatment Market, by Hospital Pharmacies
        • 10.4.2.16.4.2 Rwanda: Malaria Treatment Market, by Retail Pharmacies
      • 10.4.2.17 Nigeria
      • 10.4.2.18 Overview
        • 10.4.2.18.1 Nigeria: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.2.18.2 Nigeria: Malaria Treatment Market, by Treatment
        • 10.4.2.18.3 Nigeria: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.4.2.18.4 Nigeria: Malaria Treatment Market, by Distribution Channel
        • 10.4.2.18.4.1 Nigeria: Malaria Treatment Market, by Hospital Pharmacies
        • 10.4.2.18.4.2 Nigeria: Malaria Treatment Market, by Retail Pharmacies
      • 10.4.2.19 Ghana
      • 10.4.2.20 Overview
        • 10.4.2.20.1 Ghana: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.2.20.2 Ghana: Malaria Treatment Market, by Treatment
        • 10.4.2.20.3 Ghana: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.4.2.20.4 Ghana: Malaria Treatment Market, by Distribution Channel
        • 10.4.2.20.4.1 Ghana: Malaria Treatment Market, by Hospital Pharmacies
        • 10.4.2.20.4.2 Ghana: Malaria Treatment Market, by Retail Pharmacies
      • 10.4.2.21 Uganda
      • 10.4.2.22 Overview
        • 10.4.2.22.1 Uganda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.2.22.2 Uganda: Malaria Treatment Market, by Treatment
        • 10.4.2.22.3 Uganda: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.4.2.22.4 Uganda: Malaria Treatment Market, by Distribution Channel
        • 10.4.2.22.4.1 Uganda: Malaria Treatment Market, by Hospital Pharmacies
        • 10.4.2.22.4.2 Uganda: Malaria Treatment Market, by Retail Pharmacies
      • 10.4.2.23 Angola
      • 10.4.2.24 Overview
        • 10.4.2.24.1 Angola: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.2.24.2 Angola: Malaria Treatment Market, by Treatment
        • 10.4.2.24.3 Angola: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.4.2.24.4 Angola: Malaria Treatment Market, by Distribution Channel
        • 10.4.2.24.4.1 Angola: Malaria Treatment Market, by Hospital Pharmacies
        • 10.4.2.24.4.2 Angola: Malaria Treatment Market, by Retail Pharmacies
      • 10.4.2.25 Cameroon
      • 10.4.2.26 Overview
        • 10.4.2.26.1 Cameroon: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.2.26.2 Cameroon: Malaria Treatment Market, by Treatment
        • 10.4.2.26.3 Cameroon: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.4.2.26.4 Cameroon: Malaria Treatment Market, by Distribution Channel
        • 10.4.2.26.4.1 Cameroon: Malaria Treatment Market, by Hospital Pharmacies
        • 10.4.2.26.4.2 Cameroon: Malaria Treatment Market, by Retail Pharmacies
      • 10.4.2.27 Senegal
      • 10.4.2.28 Overview
        • 10.4.2.28.1 Senegal: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.2.28.2 Senegal: Malaria Treatment Market, by Treatment
        • 10.4.2.28.3 Senegal: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.4.2.28.4 Senegal: Malaria Treatment Market, by Distribution Channel
        • 10.4.2.28.4.1 Senegal: Malaria Treatment Market, by Hospital Pharmacies
        • 10.4.2.28.4.2 Senegal: Malaria Treatment Market, by Retail Pharmacies
      • 10.4.2.29 Zambia
      • 10.4.2.30 Overview
        • 10.4.2.30.1 Zambia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.2.30.2 Zambia: Malaria Treatment Market, by Treatment
        • 10.4.2.30.3 Zambia: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.4.2.30.4 Zambia: Malaria Treatment Market, by Distribution Channel
        • 10.4.2.30.4.1 Zambia: Malaria Treatment Market, by Hospital Pharmacies
        • 10.4.2.30.4.2 Zambia: Malaria Treatment Market, by Retail Pharmacies
      • 10.4.2.31 Rest of Middle East & Africa
      • 10.4.2.32 Overview
        • 10.4.2.32.1 Rest of Middle East & Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.2.32.2 Rest of Middle East & Africa: Malaria Treatment Market, by Treatment
        • 10.4.2.32.3 Rest of Middle East & Africa: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.4.2.32.4 Rest of Middle East & Africa: Malaria Treatment Market, by Distribution Channel
        • 10.4.2.32.4.1 Rest of Middle East & Africa: Malaria Treatment Market, by Hospital Pharmacies
        • 10.4.2.32.4.2 Rest of Middle East & Africa: Malaria Treatment Market, by Retail Pharmacies
  • 10.5 South & Central America Malaria Treatment Market, Revenue and Forecast To 2030
    • 10.5.1 Overview
    • 10.5.2 Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
      • 10.5.2.1 South & Central America: Malaria Treatment Market, by Treatment
      • 10.5.2.2 South & Central America: Malaria Treatment Market, by Route of Administration
      • 10.5.2.3 South & Central America: Malaria Treatment Market, by Distribution Channel
        • 10.5.2.3.1 South & Central America: Malaria Treatment Market, by Hospital Pharmacies
        • 10.5.2.3.2 South & Central America: Malaria Treatment Market, by Retail Pharmacies
      • 10.5.2.4 South & Central America: Malaria Treatment Market, by Countries
      • 10.5.2.5 Brazil
      • 10.5.2.6 Overview
        • 10.5.2.6.1 Brazil: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.5.2.6.2 Brazil: Malaria Treatment Market, by Treatment
        • 10.5.2.6.3 Brazil: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.5.2.6.4 Brazil: Malaria Treatment Market, by Distribution Channel
        • 10.5.2.6.4.1 Brazil: Malaria Treatment Market, by Hospital Pharmacies
        • 10.5.2.6.4.2 Brazil: Malaria Treatment Market, by Retail Pharmacies
      • 10.5.2.7 Argentina
      • 10.5.2.8 Overview
      • 10.5.2.9 Rest of South & Central America
      • 10.5.2.10 Overview
        • 10.5.2.10.1 Rest of South & Central America: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.5.2.10.2 Rest of South & Central America: Malaria Treatment Market, by Treatment
        • 10.5.2.10.3 Rest of South & Central America: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.5.2.10.4 Rest of South & Central America: Malaria Treatment Market, by Distribution Channel
        • 10.5.2.10.4.1 Rest of South & Central America: Malaria Treatment Market, by Hospital Pharmacies
        • 10.5.2.10.4.2 Rest of South & Central America: Malaria Treatment Market, by Retail Pharmacies

11. Malaria Treatment Market Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the Malaria Treatment Market
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Organic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Cipla Ltd
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Sun Pharmaceutical Industries Ltd
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Sanofi SA
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 GSK Plc
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Novartis AG
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Pfizer Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Service
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 AdvaCare Pharma USA LLC
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 VLP Therapeutics LLC
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Lupin Ltd
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms

14. Appendix

List Of Tables

  • Table 1. Malaria Treatment Market Segmentation
  • Table 2. Malaria Drugs/Vaccine/Compounds Under Clinical Development
  • Table 3. Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Hospital Pharmacies
  • Table 4. Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Retail Pharmacies
  • Table 5. North America: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 6. North America: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Route of Administration
  • Table 7. North America: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Distribution Channel
  • Table 8. North America: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Hospital Pharmacies
  • Table 9. North America: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Hospital Pharmacies
  • Table 10. US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 11. US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 12. US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 13. US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 14. US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 15. Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 16. Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 17. Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 18. Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 19. Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 20. Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 21. Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 22. Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 23. Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 24. Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 25. Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 26. Europe: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Route of Administration
  • Table 27. Europe: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Distribution Channel
  • Table 28. Europe: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Hospital Pharmacies
  • Table 29. Europe: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Hospital Pharmacies
  • Table 30. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 31. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 32. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 33. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 34. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 35. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 36. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 37. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 38. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 39. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 40. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 41. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 42. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 43. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 44. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 45. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 46. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 47. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 48. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 49. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 50. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 51. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 52. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 53. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 54. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 55. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 56. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 57. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 58. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 59. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 60. Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 61. Asia Pacific: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Route of Administration
  • Table 62. Asia Pacific: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Distribution Channel
  • Table 63. Asia Pacific: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Hospital Pharmacies
  • Table 64. Asia Pacific: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Hospital Pharmacies
  • Table 65. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 66. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 67. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 68. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 69. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 70. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 71. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 72. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 73. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 74. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 75. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 76. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 77. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 78. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 79. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 80. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 81. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 82. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 83. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 84. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 85. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 86. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 87. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 88. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 89. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 90. Middle East & Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 91. Middle East & Africa: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Route of Administration
  • Table 92. Middle East & Africa: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Distribution Channel
  • Table 93. Middle East & Africa: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Hospital Pharmacies
  • Table 94. Middle East & Africa: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Hospital Pharmacies
  • Table 95. Saudi Arabia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 96. Saudi Arabia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 97. Saudi Arabia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 98. Saudi Arabia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 99. Saudi Arabia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 100. UAE: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 101. UAE: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 102. UAE: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 103. UAE: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 104. UAE: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 105. South Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 106. South Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 107. South Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 108. South Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 109. South Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 110. Kenya: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 111. Kenya: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 112. Kenya: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 113. Kenya: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 114. Kenya: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 115. Tanzania: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 116. Tanzania: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 117. Tanzania: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 118. Tanzania: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 119. Tanzania: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 120. Rwanda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 121. Rwanda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 122. Rwanda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 123. Rwanda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 124. Rwanda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 125. Nigeria Malaria Treatment Market, by Treatment - Revenue and Forecast to 2030 (USD Million)
  • Table 126. Nigeria: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 127. Nigeria: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 128. Nigeria: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 129. Nigeria: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 130. Ghana: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 131. Ghana: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 132. Ghana: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 133. Ghana: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 134. Ghana: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 135. Uganda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 136. Uganda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 137. Uganda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 138. Uganda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 139. Uganda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 140. Angola: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 141. Angola: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 142. Angola: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 143. Angola: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 144. Angola: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 145. Cameroon: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 146. Cameroon: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 147. Cameroon: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 148. Cameroon: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 149. Cameroon: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 150. Senegal: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 151. Senegal: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 152. Senegal: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 153. Senegal: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 154. Senegal: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 155. Zambia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 156. Zambia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 157. Zambia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 158. Zambia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 159. Zambia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 160. Rest of Middle East & Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 161. Rest of Middle East & Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 162. Rest of Middle East & Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 163. Rest of Middle East & Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 164. Rest of Middle East & Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 165. South & Central America: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 166. South & Central America: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Route of Administration
  • Table 167. South & Central America: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Distribution Channel
  • Table 168. South & Central America: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Hospital Pharmacies
  • Table 169. South & Central America: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Hospital Pharmacies
  • Table 170. Brazil: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 171. Brazil: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 172. Brazil: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 173. Brazil: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 174. Brazil: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 175. Rest of South & Central America: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 176. Rest of South & Central America: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 177. Rest of South & Central America: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 178. Rest of South & Central America: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 179. Rest of South & Central America: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 180. Recent Inorganic Growth Strategies in the Malaria Treatment Market
  • Table 181. Recent Organic Growth Strategies in the Malaria Treatment Market
  • Table 182. Glossary of Terms, Malaria Treatment Market

List Of Figures

  • Figure 1. PEST Analysis - Malaria
  • Figure 2. Malaria Treatment Market - Key Industry Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Malaria Treatment Market Revenue (US$ million), 2020 - 2030
  • Figure 5. Malaria: Geography Analysis Market Revenue (US$ million), 2022 - 2030
  • Figure 6. Malaria Treatment Market Revenue Share, by Treatment 2022 & 2030 (%)
  • Figure 7. Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 8. Generic Drugs Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 9. Originators Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 10. Others Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 11. Malaria Treatment Market Revenue Share, by Route of Administration 2022 & 2030 (%)
  • Figure 12. Oral: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Parenteral: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Malaria Treatment Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
  • Figure 15. Direct Tender: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Hospital Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Retail Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Online Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Online Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. North America Malaria Treatment Market, By Geography, 2022 ($Mn)
  • Figure 21. Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 22. North America: Malaria Treatment Market, By Key Countries, 2022 And 2030 (%)
  • Figure 23. US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 24. Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 25. Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 26. Europe Malaria Treatment Market, By Geography, 2022 ($Mn)
  • Figure 27. Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 28. Europe: Malaria Treatment Market, By Key Countries, 2022 And 2030 (%)
  • Figure 29. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 30. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 31. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 32. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 33. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 34. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 35. Malaria Treatment Market, 2022 ($Mn)
  • Figure 36. Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 37. Asia Pacific: Malaria Treatment Market, By Key Countries, 2022 And 2030 (%)
  • Figure 38. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 39. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 40. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 41. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 42. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 43. Malaria Treatment Market, 2022 (US$ Mn)
  • Figure 44. Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 45. Middle East & Africa: Malaria Treatment Market, By Key Countries, 2022 And 2030 (%)
  • Figure 46. Saudi Arabia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 47. UAE: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 48. South Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 49. Kenya: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 50. Tanzania: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 51. Rwanda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 52. Nigeria: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 53. Ghana: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 54. Uganda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 55. Angola: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 56. Cameroon: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 57. Senegal: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 58. Zambia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 59. Rest of Middle East & Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 60. Malaria Treatment Market, 2022 ($Mn)
  • Figure 61. Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 62. South & Central America: Malaria Treatment Market, By Key Countries, 2022 And 2030 (%)
  • Figure 63. Brazil: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 64. Rest of South & Central America: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 65. Growth Strategies in the Malaria Treatment Market